Mawer Investment Management
RMD icon

Mawer Investment Management’s ResMed RMD Stock Holding History

Mawer Investment Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.4M Buy
89,367
+5,360
+6% +$1.11M 0.12% 94
2026
Q1 		$18.9M Buy
84,007
+11,053
+15% +$2.75M 0.12% 88
2025
Q4 		$17.6M Sell
72,954
-4,582
-6% -$1.17M 0.1% 84
2025
Q3 		$21.2M Sell
77,536
-434
-0.6% -$119K 0.11% 84
2025
Q2 		$20.1M Sell
77,970
-2,710
-3% -$646K 0.1% 86
2025
Q1 		$18.1M Sell
80,680
-6,763
-8% -$1.58M 0.09% 81
2024
Q4 		$20M Buy
87,443
+10,889
+14% +$2.62M 0.09% 79
2024
Q3 		$18.7M Buy
76,554
+2,394
+3% +$535K 0.09% 77
2024
Q2 		$14.2M Buy
74,160
+21,306
+40% +$4.32M 0.07% 81
2024
Q1 		$10.5M Buy
52,854
+30,764
+139% +$5.64M 0.05% 79
2023
Q4 		$3.8M Buy
+22,090
New +$3.39M 0.02% 88

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Mawer Investment Management's RMD Position: Q2 2026 in Review

Mawer Investment Management increased its ResMed (RMD) stake by 6.4% in Q2 2026, buying an estimated $1.11M and bringing the position to 89,367 shares worth $17.4M. The position accounts for 0.12% of the portfolio, ranked #94.

Mawer Investment Management first reported a position in RMD in Q4 2023 and has held it in 11 quarters since. The position peaked at $21.2M in Q3 2025. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Mawer Investment Management held 89,367 shares of ResMed worth $17.4M as of Q2 2026.
  • Mawer Investment Management bought 5,360 ResMed shares in Q2 2026, an estimated $1.11M.
  • ResMed made up 0.12% of Mawer Investment Management's portfolio in Q2 2026, its #94 holding.
  • Mawer Investment Management first reported a position in ResMed in Q4 2023 and has held it in 11 quarters since.
  • Mawer Investment Management's ResMed position peaked at $21.2M in Q3 2025.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Mawer Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.